Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer

High-dose-rate brachytherapy (HDR-BT) with external beam radiation therapy (EBRT) is a common treatment option for locally advanced prostate cancer (PCa). Seventy-nine male patients (median age 71 years, range 50 to 79) with high-risk PCa underwent HDR-BT following EBRT between December 2009 and Jan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ecke, Thorsten H., Huang-Tiel, Hui-Juan, Golka, Klaus, Selinski, Silvia, Geis, Berit Christine, Koswig, Stephan, Bathe, Katrin, Hallmann, Steffen, Gerullis, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133879/
https://www.ncbi.nlm.nih.gov/pubmed/27834929
http://dx.doi.org/10.3390/ijms17111879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133879/
https://www.ncbi.nlm.nih.gov/pubmed/27834929
http://dx.doi.org/10.3390/ijms17111879

Ejemplares similares